The Non-Consensus
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Tesla: Expanding Auto Segments, Margins, and Multiples
Investors increasingly view the market as a bifurcation with long duration, hyper growth, and meme stocks on one end, and high quality and…
Jan 4, 2022
2
Share this post
Tesla: Expanding Auto Segments, Margins, and Multiples
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
November 2021
WeWork: A Strongly Profitable Business That Just Needs the Bananas to Ripen
Summary While obscured by a tarnished reputation and suppressed pandemic-related occupancy rates, WeWork is a highly-profitable leader in a fast-growing…
Nov 23, 2021
3
Share this post
WeWork: A Strongly Profitable Business That Just Needs the Bananas to Ripen
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
1
My Substack Introduction
What I'm doing here
Nov 12, 2021
3
Share this post
My Substack Introduction
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
May 2020
The Case for Beating the Market, Part 1
Why I have an active investing approach despite the conventional wisdom
May 11, 2020
5
Share this post
The Case for Beating the Market, Part 1
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
December 2019
Biogen: Aducanumab Questions Linger After CTAD, but Trading Opportunities Exist
Summary On Thursday, Biogen presented additional aducanumab data at CTAD that answered some questions, and raised others Bulls believe the totality of…
Dec 6, 2019
1
Share this post
Biogen: Aducanumab Questions Linger After CTAD, but Trading Opportunities Exist
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
November 2019
Amarin: Low Compliance and Competition Key to Bear Thesis, but Bulls Don't See the Threat
Summary In this note, I detail some common elements of the bear thesis, as well as the counterarguments to this thesis. Low compliance serves as a risk…
Nov 26, 2019
1
Share this post
Amarin: Low Compliance and Competition Key to Bear Thesis, but Bulls Don't See the Threat
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
Peloton: Creating a New Fitness Category, or the Next Fitness Fad?
Summary Is Peloton the next short-lived fitness fad? Peloton has a lasting product with the engagement of a live class and the convenience of a home…
Nov 11, 2019
Share this post
Peloton: Creating a New Fitness Category, or the Next Fitness Fad?
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
October 2019
Reata: A "Show Me" Story Showing the Results and with Two Upcoming Catalysts
Strong omaveloxolone results in FA was a surprise and could generate $1B+ in sales. Importantly, their Nrf2 activators could potentially treat many…
Oct 21, 2019
Share this post
Reata: A "Show Me" Story Showing the Results and with Two Upcoming Catalysts
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
Zillow: Digitizing the Home Buying Experience
Summary Zillow, Redfin, and Opendoor are all looking to improve the archaic buying experience in real estate through iBuying and offering adjacent…
Oct 1, 2019
Share this post
Zillow: Digitizing the Home Buying Experience
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
April 2019
Tesla: Story Still Hinges on Demand after Autonomy Day and 1Q Results
My last post on Tesla was just before two major events - Tesla's Autonomy Investor Day, and Tesla's 1Q earnings results. Here are my thoughts following…
Apr 27, 2019
Share this post
Tesla: Story Still Hinges on Demand after Autonomy Day and 1Q Results
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
Tesla: 1Q Issues Reduce Demand Visibility, but Long-Term Demand Still Appears Healthy
- Tesla saw 1Q deliveries fall short of expectations, leading to demand concerns. The key question is whether this is a temporary blip or an ongoing…
Apr 22, 2019
1
Share this post
Tesla: 1Q Issues Reduce Demand Visibility, but Long-Term Demand Still Appears Healthy
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
March 2019
Gilead: What Will Provide the Growth Needed for Multiple Expansion?
- In order to outperform, Gilead will need to generate higher revenue growth going forward - HIV franchise sales will depend on Gilead’s ability to…
Mar 25, 2019
Share this post
Gilead: What Will Provide the Growth Needed for Multiple Expansion?
thenonconsensus.substack.com
Copy link
Facebook
Email
Note
Other
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts